CLINICAL_TRIALS
trial_result
· 2021-05-06
Clinical Trial Update: A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation [Phase 2]
Summary
A Phase 2 randomized controlled trial evaluating Thymoglobulin after liver transplantation has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Cleveland Clinic | Conditions: Liver Failure | Phase 2 | Status: COMPLETED | Results posted: 2021-05-06